Icure Pharmaceutical Incorporation (KOSDAQ:175250)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,170.00
+231.00 (11.91%)
At close: Aug 5, 2025

KOSDAQ:175250 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
8,27017,1846,33250,56917,806
Short-Term Investments
2,7405,250340.19360.19745
Trading Asset Securities
-2.191,8862,8565,866
Cash & Short-Term Investments
11,01022,4378,55853,78624,417
Cash Growth
-50.93%162.17%-84.09%120.28%77.99%
Accounts Receivable
12,99910,5827,7268,17410,153
Other Receivables
208.85729.74194.11509.921,774
Receivables
13,20812,7728,76015,88416,978
Inventory
8,92012,89713,01910,54616,977
Prepaid Expenses
134.45139.83116.2180.58129.48
Other Current Assets
1,164326.62654.81408.36294.83
Total Current Assets
34,43648,57231,10880,70558,796
Property, Plant & Equipment
48,79464,52993,52696,943101,312
Long-Term Investments
871.971,6599,41611,00122,675
Goodwill
-1,6012,8582,8584,150
Other Intangible Assets
425.921,8292,3812,9803,081
Long-Term Accounts Receivable
-83.93---
Long-Term Deferred Tax Assets
-1,172774.48530.59-
Long-Term Deferred Charges
-5,0309,0209,7018,622
Other Long-Term Assets
4,6618,52617,14418,41216,794
Total Assets
90,500133,618166,844224,121215,448
Accounts Payable
8,1666,6857,2916,4616,155
Accrued Expenses
513.9700.15755.32718.82496.54
Short-Term Debt
20,54032,16956,27673,52110,050
Current Portion of Long-Term Debt
1,0191,55612,7663,74732,120
Current Portion of Leases
1,3111,23477.56171.09185.44
Current Unearned Revenue
-242.6106.0823.75-
Other Current Liabilities
23,91621,74715,77425,3395,811
Total Current Liabilities
55,46664,33393,045109,98154,818
Long-Term Debt
666.634,3524,8629,45031,650
Long-Term Leases
4,1181,12934.72120.83180.31
Pension & Post-Retirement Benefits
508.82-5,9072,8782,465
Long-Term Deferred Tax Liabilities
----16.36
Other Long-Term Liabilities
2,2202,1122,8529,83327,615
Total Liabilities
62,98071,927106,700132,262116,744
Common Stock
18,77918,77918,77918,7799,446
Additional Paid-In Capital
134,882133,428133,401133,434107,271
Retained Earnings
-124,907-91,382-93,734-60,603-18,969
Treasury Stock
-3,707-3,707-3,707-3,707-3,160
Comprehensive Income & Other
1,2981,3941,6571,7691,168
Total Common Equity
26,34558,51256,39589,67195,755
Minority Interest
-1,888471.811,3552,1882,949
Shareholders' Equity
27,52061,69160,14491,85998,704
Total Liabilities & Equity
90,500133,618166,844224,121215,448
Total Debt
27,65540,44074,01587,00974,186
Net Cash (Debt)
-16,645-18,003-65,457-33,224-49,769
Net Cash Per Share
-444.36-481.04-1742.81-1426.23-2298.37
Filing Date Shares Outstanding
37.0537.3737.3737.3722.51
Total Common Shares Outstanding
37.0537.3737.3737.3722.51
Working Capital
-21,030-15,762-61,937-29,2763,979
Book Value Per Share
711.001565.771509.112399.564254.76
Tangible Book Value
25,91955,08151,15683,83288,524
Tangible Book Value Per Share
699.511473.961368.912243.323933.45
Land
5,6748,30525,62624,37825,388
Buildings
38,86047,34652,38452,05350,835
Machinery
22,22732,62736,26533,83030,572
Construction In Progress
395.41,209259.66917.823,422
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.